FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-6319com.
(The FASEB Journal. 2007;21:1433-1444.)
© 2007 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-6319comv1
21/7/1433    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoudjehane, L.
Right arrow Articles by Conti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoudjehane, L.
Right arrow Articles by Conti, F.

Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway

Lynda Aoudjehane*, Philippe Podevin*, Olivier Scatton{dagger}, Patrick Jaffray{ddagger}, Isabelle Dusanter-Fourt§, Gérard Feldmann||, Pierre-Philippe Massault{dagger}, Lilia Grira{ddagger}, Annie Bringuier||, Bertrand Dousset{dagger}, Sandrine Chouzenoux*, Olivier Soubrane{dagger}, Yvon Calmus* and Filomena Conti*

* Laboratoire de Biologie Cellulaire, UPRES 1833, Université Paris5;

{dagger} Service de Chirurgie, Hôpital Cochin, APHP;

{ddagger} Laboratoire de Biochimie, Hôpital Cochin, APHP;

§ Département d’Hématologie, Institut Cochin, INSERM U567, Paris, France; and

|| Laboratoire de Biologie Cellulaire, INSERM U327, Faculté Xavier Bichat, Paris, France

1Correspondence: Service de Chirurgie, Hôpital Cochin, 75674 Paris Cedex 14, France. E-mail: filomena.conti{at}cch.aphp.fr

IL-4 is overexpressed in liver grafts during severe recurrent hepatitis C and rejection. Hepatocyte apoptosis is involved in both these phenomena. We therefore examined the proapoptotic effect of IL-4 on HepG2 cells and human hepatocytes in vitro, together with the underlying mechanisms. We first measured IL-4 receptor expression, STAT6 activation by IL-4, and STAT6 inhibition by an anti-IL-4 antibody or by STAT6 siRNA transfection. We then focused on the pathways involved in IL-4-mediated apoptosis and the role of STAT6 activation in apoptosis initiation. The IL-4 receptor was expressed on both cell types, and STAT6 was activated by IL-4. Both anti-IL-4 and STAT-6 siRNA inhibited this activation. IL-4 induced apoptosis of both HepG2 cells (P=0.008 vs. untreated control) and human hepatocytes (P<0.001 vs. untreated control). IL-4 reduced the mitochondrial membrane potential, activated Bid and Bax, and augmented caspase 3, 8, and 9 activity. STAT6 blockade inhibited IL-4-induced apoptosis. Expression of Fas and Fas ligand was unaffected when HepG2 cells and hepatocytes were cultured with IL-4, and Fas/FasL pathway blockade failed to inhibit IL-4-induced apoptosis. These results show that IL-4 induces apoptosis of human hepatocytes through IL-4 receptor binding, STAT6 activation, decreased mitochondrial membrane potential, and increased caspase activation, independently of the Fas pathway. IL-4 might thus contribute to the progression of severe liver graft damage.—Aoudjehane, L., Podevin, P., Scatton, O., Jaffray, P., Dusanter-Fourt, I., Feldmann, G., Massault, P. P., Grira, L., Bringuier, A., Dousset, B., Chouzenoux, S., Soubrane, O., Calmus, Y., Conti, F. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway.


Key Words: liver transplantation • IL-4







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.